Aller au contenu principal

First patient treated with FLASH-radiotherapy LINAC at CHUV (Switzerland)

First patient treated with FLASH-radiotherapy LINAC at CHUV (Switzerland)

07 Nov 2019

chuv flash radiotherapy partnership pmb alcen

PMB is proud to have partnered with the University Hospital of Lausanne (CHUV) for the first treatment of a human patient with FLASH-radiotherapy, in Switzerland. A 75-year-old patient with multiple skin tumors, was treated using the ORIATRON eRT6, a LINAC specifically engineered to safely accelerate electrons in a “FLASH” mode. 

This first patient treatment is the positive outcome of several years of fruitful partnership between PMB and CHUV and represents a paradigm shift in the field of radiation therapy.

Why FLASH-radiotherapy? 

Many technological advances have made radiation therapy a powerful treatment for patients. However, the efficiency of conventional radiotherapy, which is carried out in several minutes, is limited by the complications and damage caused on surrounding normal tissue. 

FLASH-radiotherapy delivers a much higher dose in a few microseconds, destroying cancerous cells without causing any collateral damage to normal tissue, to an extent that was never possible with conventional radiotherapy. FLASH-radiotherapy gives great hope to cancer patients all over the world and shall revolutionize radiation therapy in the near future, making it safer, more precise and more efficient. 

PMB is currently developing a device for clinical applications. More information will be released soon. 
 


 

Pre-clinical & clinical evidence using the Linac Oriatron eRT6 Other research made on the FLASH effect